All Reviews/Perspectives

18. Wood, K.C. (2023). Hyperactivation of oncogenic driver pathways as a precision therapeutic strategy, Nature Genetics 55,1613-1614. [Pubmed][PDF]

17. Killarney, S.T.; Tait, S.W.G.; Green, D.R.*; Wood, K.C.* (2023). Sublethal engagement of apoptotic pathways in residual cancer, Trends in Cell Biology 34, 225-238. (*Co-corresponding authors) [Pubmed][PDF]

16. Sarosiek, K.*; Wood, K.C.* (2023). Endogenous and imposed determinants of apoptotic vulnerabilities in cancer, Trends in Cancer 9, 96-110. [Pubmed][PDF]

15. Wood, K.C.*; Gutkind, J.S.* (2022). Challenges and emerging opportunities in targeting mTOR in cancer, Cancer Research 82, 3884-3887. [Pubmed][PDF]

14. Wood, K.C. (2022). Drivers of intrinsic resistance, Nature Chemical Biology 18, 579-81. [Pubmed][PDF]

13. Wood, K.C. (2020). Overcoming MCL-1-driven adaptive resistance to targeted therapies, Nature Communications 11, 531. [Pubmed][PDF]

12. Winter, P.S.; Wood, K.C. (2018). Mapping effector-phenotype landscapes in KRAS-driven cancers, Trends in Cancer 4, 333-335. [Pubmed][PDF]

11. Wood, K.C. (2017). Suppressing oncogenic transcription with a little healthy competition, Science Translational Medicine 9, 374eaaI5000. [Pubmed][Link]

10. Wood, K.C. (2016). An EXITS strategy for decreasing cancer risk in women, Science Translational Medicine 8, 368ec197. [Pubmed][Link]

9. Wood, K.C. (2016). Hacking T cells with synthetic circuits to program antitumor responses, Science Translational Medicine 8, 362ec172. [Link]

8. Singleton, K.R.; Wood, K.C. (2016). Narrowing the focus: A toolkit to systematically connect oncogenic signaling pathways with cancer phenotypes, Genes Cancer 7(7-8), 218-228. [Pubmed][PDF]

7. Wood, K.C. (2016). Two faces of circulating breast cancer cells, Science Translational Medicine 8(356), 356ec149. [Link]

6. Wood, K.C. (2016). Mapping a path for precision cancer therapies, Science Translational Medicine 8(348), 348ec115. [Link]

5. Wood, K.C. (2016). Targeting the cancer cells that just won’t go away, Science Translational Medicine 8(344), 344ec101. [Link]

4. Wood, K.C. (2016). Collaborating tumor cells overcome multitargeted antiangiogenic therapies, Science Translational Medicine 8(338), 338ec77. [Link]

3. Wood, K.C. (2016). Intercepting reversible drug tolerance to improve targeted therapy, Science Translational Medicine 8(322), 332ec52. [Link]

2. Wood, K.C. (2015). Mapping the pathways of resistance to targeted therapies, Cancer Research 75, 4247-51. [Pubmed][PDF]

1. Wood, K.C.; Sabatini, D.M. (2009). Growth signaling at the nexus of stem cell life and death, Cell Stem Cell 5, 232-234. [Pubmed][PDF]